Xuexin Li
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Editorial: Artificial intelligence in multi-omics: advancing tumor metastasis prediction and mechanism analysis.
Journal: Frontiers in cell and developmental biology
Published: July 01, 2026
Nanoparticles for autoimmune diseases: advancing diagnostics and therapeutic solutions.
Journal: Acta pharmacologica Sinica
Published: May 21, 2025
Clear cell renal carcinoma essentially requires CDKL3 for oncogenesis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 12, 2025
Mitochondria-derived vesicles: A promising and potential target for tumour therapy.
Journal: Clinical and translational medicine
Published: December 01, 2024
Molecular Profiling Defines Three Subtypes of Synovial Sarcoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 29, 2024
HNF4α-CDKL3 axis restricts MASLD progression by targeting FoxO1 via noncanonical phosphorylation.
Journal: Hepatology (Baltimore, Md.)
Published: April 15, 2024
Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy.
Journal: Acta pharmaceutica Sinica. B
Published: November 26, 2023
The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ.
Journal: EBioMedicine
Published: October 13, 2023
Universal cutoff for tumor mutational burden in predicting the efficacy of anti-PD-(L)1 therapy for advanced cancers.
Journal: Frontiers in cell and developmental biology
Published: April 20, 2023
Immunotherapy in gastrointestinal cancers: advances, challenges, and countermeasures.
Journal: Science bulletin
Published: April 01, 2023
mRNA vaccine in cancer therapy: Current advance and future outlook.
Journal: Clinical and translational medicine
Published: January 25, 2023
COVID-19 associated liver injury: An updated review on the mechanisms and management of risk groups.
COVID-19 associated liver injury: An updated review on the mechanisms and management of risk groups.
Journal: Liver research (Beijing, China)
Published: December 13, 2022
Last Updated: 09/26/2026